Your session is about to expire
← Back to Search
Peer mentorship for Suicidal Thoughts (PREVAIL Trial)
N/A
Waitlist Available
Led By Paul Pfeiffer, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months
Awards & highlights
PREVAIL Trial Summary
This trial will test a promising, scalable intervention with a novel approach to addressing the risk factors advocated by the Surgeon General for reducing suicide attempts and suicidal ideation among recently hospitalized adult psychiatric patients at high risk for suicide.
Eligible Conditions
- Suicidal Thoughts
PREVAIL Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Suicide attempts (measured by the Columbia Suicide Severity Rating Scale)
Secondary outcome measures
Self efficacy to avoid suicidal action (measured by the Self Efficacy to Avoid Suicidal Action Scale)
Feeling suicidal (finding)
Suicide attempts (measured by the medical record)
Other outcome measures
Burdensomeness (measured by the Burdensomeness sub scale of the Interpersonal Needs Questionnaire (INQ))
Depression (measured by the Patient Health Questionnaire (PHQ-9))
Subfascicular nucleus
+13 morePREVAIL Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Peer Mentorship interventionExperimental Treatment1 Intervention
A Peer Specialist will be making weekly follow-up contact with study participants in the community or by telephone for 3 months following hospital discharge. The content of the peer mentorship interactions will be based on the manual developed by the study team and will address protective factors such as hope and belongingness.
Group II: Enhanced Usual Care (EUC)Active Control1 Intervention
The EUC condition will consist of a "caring message" from the study team via e-mail or text message (based on the participant's preference) 24-72 hours after discharge. An example message is, "We hope things are going well for you since you left the hospital. If you wish to reply, we'd be glad to hear from you". A list of local mental health resources will be available if participants reply and during the 3 and 6-month follow-up assessments. The EUC condition is modeled on prior studies of caring letters and brief contacts by health professionals after suicidal crisis and national recommendations to provide post-crisis follow-up contacts.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer mentorship
2018
N/A
~800
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,688,652 Total Patients Enrolled
1 Trials studying Suicidal Thoughts
240 Patients Enrolled for Suicidal Thoughts
University of MichiganLead Sponsor
1,794 Previous Clinical Trials
6,373,461 Total Patients Enrolled
Paul Pfeiffer, MDPrincipal InvestigatorUniversity of Michigan
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have significant problems with thinking and memory, as assessed by a test called the Mini-Cog.You are currently getting or planning to get regular support from a mentor or group for your alcohol recovery more than twice a month.You are currently undergoing electroconvulsive therapy.Your score on the Beck Suicide Scale was 5 or higher in the week leading up to admission.
Research Study Groups:
This trial has the following groups:- Group 1: Peer Mentorship intervention
- Group 2: Enhanced Usual Care (EUC)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies open to participants in this trial?
"Per the information found on clinicaltrials.gov, recruiting for this medical trial has been suspended since July 19th 2022. Initially posted in June 2018, it is no longer seeking individuals to participate; however there are still 217 other trials actively enrolling participants at present."
Answered by AI
Share this study with friends
Copy Link
Messenger